Data Composite

Remifentanil Hydrochloride Injection Shortage

9 of 9 tracked records currently active across 3 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Mylan Institutional, a Viatris Company ULTIVA Current 10/19/2026
Mylan Institutional, a Viatris Company ULTIVA Current 10/19/2026
Mylan Institutional, a Viatris Company ULTIVA Current 10/19/2026
Fresenius Kabi USA, LLC REMIFENTANIL HYDROCHLORIDE Current 10/15/2026
Fresenius Kabi USA, LLC REMIFENTANIL HYDROCHLORIDE Current 10/15/2026
Fresenius Kabi USA, LLC REMIFENTANIL HYDROCHLORIDE Current 10/15/2026
Hikma Pharmaceuticals USA, Inc. REMIFENTANIL HYDROCHLORIDE Current 10/14/2026
Hikma Pharmaceuticals USA, Inc. REMIFENTANIL HYDROCHLORIDE Current 10/14/2026
Hikma Pharmaceuticals USA, Inc. REMIFENTANIL HYDROCHLORIDE Current 10/14/2026

← All shortages